Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17914062 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
Condition: Migraine
Interventions: Drug: Comparator: Placebo;   Drug: MK0974;   Drug: Rizatriptan

Indicates status has not been verified in more than two years